QualMetrix closes oversubscribed Series A financing round

QualMetrix, Inc., a healthcare analytics company delivering actionable insights to payers, providers, pharma and employers to help them reduce cost while enhancing the quality of healthcare, announced the close of an oversubscribed Series A financing round.

"We are excited about the numerous achievements made in recent months as we continue to invest in our highly experienced and skilled management team and a world class product platform back by our expert team of medical directors and healthcare experts," said Lawrence Schimmel, M.D., Chairman. "With the funding provided to date, we believe that QualMetrix is well positioned to accelerate on the delivery of our QM^(x)TM Software as a Service (SaaS) platform, further build out our sales and marketing team, and execute on our strategic vision. We have signed and confirmed business on hand and continue to receive consistent positive feedback from healthcare and financial professionals on our secure, cloud-based web delivery portal."

"Completing our Series A financing puts our focus on acceleration of delivery to meet the rapid growth in the healthcare analytics market, a market expected to reach $10.8 billion by 2017. A growing and essential market driven by federal healthcare mandates, advancement of analytical technologies, and the emergence of big data," added Adam House Sr., Chief Executive Officer. "We believe that this financing, together with our acquisition of the Visual Intelligence healthcare analytics platform, our hiring Cristian Ilie as our CTO, and our retaining Dr. Don Grossman on our Medical Advisory Board demonstrate our expertise in this market to deliver actionable insights needed by today's medical leaders."